Skip to main content

Pliant Therapeutics, Inc.

PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746473

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Pliant Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PLRX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7681+5
Shares30.7M30.7M−29.1K (−0.1%)
Value$1.21B$893.6M−$314.6M (−26.0%)

New holders (12)

Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PLRX in Q2 2021
InstitutionSharesValue% of portfolio
Fernwood Investment Management, LLC151,111$4.41M1.46%
Bond & Devick Financial Network, Inc.120,160$3.50M2.89%
Woodline Partners LP71,663$2.09M0.04%
Sphera Funds Management Ltd.51,000$1.49M0.14%
Russell Investments Group, Ltd.29,182$848.0K0.00%
ExodusPoint Capital Management, LP14,499$422.0K0.01%
Invesco Ltd.9,503$276.0K0.00%
Nisa Investment Advisors, LLC1,400$41.0K0.00%
Parallel Advisors, LLC658$19.0K0.00%
Laurel Wealth Advisors LLC160$5.00K0.00%
Captrust Financial Advisors76$2.00K0.00%
Clearstead Advisors, LLC40$1.00K0.00%

Sold out (7)

Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of PLRX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
California Public Employees Retirement System16,800$661.0K
DuPont Capital Management Corp13,850$545.0K
Principal Financial Group Inc8,635$340.0K
HC Advisors, LLC5,493$216.0K
SG Americas Securities, LLC4,553$179.0K
Newbridge Financial Services Group, Inc.1,000$39.0K
Bank of Montreal868$32.0K